Effect of Omacor on Triglycerides in HIV Infected Subjects

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

NCT00386971 ·Status: COMPLETED ·Phase: NA

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

NCT00705926 ·Status: COMPLETED ·Phase: PHASE1

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

NCT01458977 ·Status: COMPLETED ·Phase: PHASE4

Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane

NCT00931268 ·Status: COMPLETED ·Phase: NA

Anti-HIV Medications for People Recently Infected With HIV

NCT00106171 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

NCT00122655 ·Status: TERMINATED ·Phase: PHASE4

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

NCT00076518 ·Status: COMPLETED ·Phase: PHASE2

Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients

NCT00128908 ·Status: TERMINATED ·Phase: PHASE4

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

NCT00196612 ·Status: COMPLETED ·Phase: PHASE3

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

NCT00532168 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Clinical Study of KL-HIV-Tri01 in the Treatment of HIV Infected Subjects

NCT06117657 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

NCT01266902 ·Status: COMPLETED ·Phase: PHASE3

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

NCT00608569 ·Status: COMPLETED ·Phase: NA

Intermittent Versus Continuous Medication in the Treatment of HIV

NCT00001967 ·Status: COMPLETED ·Phase: PHASE4

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

NCT00100984 ·Status: TERMINATED ·Phase: PHASE4

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

NCT00966329 ·Status: COMPLETED ·Phase: PHASE4

Atorvastatin for HAART Suboptimal Responders

NCT01766076 ·Status: COMPLETED ·Phase: PHASE3

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

NCT01515813 ·Status: WITHDRAWN ·Phase: PHASE2

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

NCT00385957 ·Status: COMPLETED ·Phase: PHASE4

Garlic in Hyperlipidemia Caused by HAART

NCT00029250 ·Status: WITHDRAWN ·Phase: PHASE2

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

NCT01351025 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

NCT00122668 ·Status: TERMINATED ·Phase: PHASE4

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

NCT00075907 ·Status: COMPLETED ·Phase: PHASE3

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

NCT00028314 ·Status: COMPLETED ·Phase: NA

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

NCT00646984 ·Status: COMPLETED ·Phase: PHASE4